The Edmonton S2BN Chapter partners with regional stakeholders to organize career development and networking events for STEM and Health/Life Sciences graduate trainees. Our aim is to support the growth of Alberta's Health and Life Sciences sector by preparing highly qualified personnel for a career path outside of academia.
We're recruiting new volunteers for 2019-2020! If you're interested in joining the S2BN Edmonton Team, email us at
Contact the University of Alberta S2BN Chapter at:
Farah Elawar
President
PhD Candidate
Farah is a Ph.D. student in the Department of Medical Microbiology & Immunology. Her research is on the epidemiology of Respiratory Syncytial Virus (RSV) in North America. By sequencing clinical isolates, we are better able to elucidate viral behaviour in the community, thereby improving public health surveillance of this seasonal virus.
Gina Sykes
Executive Team Member
MSc student
Gina is an M.Sc. student in the Division of Neurology with the Department of Medicine at the University of Alberta. She is researching the acute immune response to ischemic stroke in elderly stroke patients with the goal of providing insights to help improve stroke outcome.
Cameron Smithers
Executive Team Member
PhD Student
Cameron joined S2BN to share his passion for startup’s and the innovation ecosystem. He is a Ph.D. candidate in Biochemistry Department at the University of Alberta. His research investigating how proteins recognize specific fat molecules in a cell. A better understanding of this process will open unique avenues for targeted disease therapy.
Brittany Umer
Executive Team Member
PhD Student
Brittany is a PhD student in the Medical Microbiology and Immunology program the University of Alberta. Her research investigates methods of improving oncolytic vaccinia virus immunotherapy for breast cancer treatment.
Jay Gamma
Executive Team Member
MSc Student
Jay is an MSc student in the Department of Medicine at the University of Alberta. His research is exploring the importance of myristoylation in Acute Myeloid Leukemia, and assess the efficacy and functionality of Pacylex Pharmaceutical's drug candidate PCLX-001 as a novel, first-in-class treatment for AML and related cancers.
Quinn Storozynsky
Executive Team Member
PhD Candidate
Quinn is pursuing a Ph.D. through the Department of Oncology. His research focuses on improving the treatment of aggressive brain cancers by combining oncolytic vaccinia virus immunotherapy with radiotherapy. He hopes new knowledge generated through his studies will reveal strategies for killing cancer cells resistant to, or “missed” by radiotherapy– preventing deadly cancer recurrences and uncovering more effective cancer treatment strategies.
Mira Shenouda
Marketing Coordinator
PhD Candidate
Mira is a Ph.D. candidate in the Department of Medical Microbiology & Immunology at the University of Alberta. Her research focuses on using a state-of-the-art technique to study unique genetic elements in the vaccinia virus genome that play a role in virus attenuation. The approach used in her research can revolutionize the ability to make safer vaccine vectors and personalized therapies for cancer in a timely manner, leading to better patient outcome.
_LS.jpg)
Lindsey Suh
Event Organizer
MSc student
Lindsey is a M.Sc. student in the Pharmacy and Pharmaceutical Sciences. Her research focuses on peroxidase-mediated drug metabolism and the effect of the antioxidant drug edaravone on cellular redox balance in human granulocytes.
